Germany
Japan
United Kingdom
China
Antibodies
View as table Download
CTLA4 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 49-223 of human CTLA4 (NP_005205.2). |
| Modifications | Unmodified |
CTLA4 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 16-66 of human CTLA4 (NP_005205.2). |
| Modifications | Unmodified |
CTLA4 Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 36-161 of human CTLA4 (NP_005205.2). |
| Modifications | Unmodified |
Recombinant Anti-CTLA-4 (Clone 9H10)
| Applications | ELISA, FC, Neutralize, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CTLA-4 (Clone 9D9)
| Applications | IF |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Target Symbol
- CTLA4
Antibody Hosts
- Rabbit
Conjugates
- Unconjugated
Filter by
Category
Isotypes
Clonalities
Modifications
- Unmodified (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)